AvePoint (NASDAQ:AVPT) Insider Sells $141,100.00 in Stock

AvePoint, Inc. (NASDAQ:AVPT – Get Free Report) insider Brian Brown sold 10,000 shares of AvePoint stock in a transaction on Wednesday, September 30th. The stock was sold at an average price of $14.11, for a total value of $141,100.00. Following the sale, the insider owned 364,604 shares in the company, valued at $5,144,562.44. The trade was a 2.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Brian Michael Brown also recently made the following trade(s):

  • On Wednesday, September 23rd, Brian Brown sold 10,000 shares of AvePoint stock. The shares were sold at an average price of $13.07, for a total transaction of $130,700.00.
  • On Thursday, August 27th, Brian Brown sold 60,000 shares of AvePoint stock. The stock was sold at an average price of $14.20, for a total transaction of $852,000.00.
  • On Monday, August 24th, Brian Brown sold 10,000 shares of AvePoint stock. The shares were sold at an average price of $13.30, for a total transaction of $133,000.00.
  • On Wednesday, July 29th, Brian Brown sold 5,176 shares of AvePoint stock. The shares were sold at an average price of $13.06, for a total transaction of $67,598.56.
  • On Tuesday, July 28th, Brian Brown sold 4,824 shares of AvePoint stock. The stock was sold at an average price of $13.08, for a total transaction of $63,097.92.

AvePoint Stock Performance

Shares of NASDAQ AVPT opened at $14.07 on Monday. The stock has a fifty day simple moving average of $13.33 and a two-hundred day simple moving average of $11.60. AvePoint, Inc. has a 1-year low of $8.84 and a 1-year high of $15.58. The firm has a market cap of $2.98 billion, a price-to-earnings ratio of 43.97 and a beta of 1.17.

AvePoint (NASDAQ:AVPT – Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.04. The firm had revenue of $124.50 million for the quarter, compared to analyst estimates of $121.38 million. AvePoint had a return on equity of 15.97% and a net margin of 15.33%. Analysts forecast that AvePoint, Inc. will post 0.25 EPS for the current year.

Institutional Investors Weigh In On AvePoint

A number of institutional investors and hedge funds have recently made changes to their positions in AVPT. Dimensional Fund Advisors LP grew its position in AvePoint by 25.7% during the first quarter. Dimensional Fund Advisors LP now owns 3,264,082 shares of the company’s stock worth $31,040,000 after buying an additional 666,422 shares in the last quarter. Wellington Management Group LLP raised its holdings in shares of AvePoint by 106.7% in the 2nd quarter. Wellington Management Group LLP now owns 2,776,579 shares of the company’s stock valued at $31,125,000 after acquiring an additional 1,433,299 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its position in shares of AvePoint by 25.0% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,675,587 shares of the company’s stock valued at $25,445,000 after acquiring an additional 535,015 shares during the last quarter. Renaissance Technologies LLC boosted its position in shares of AvePoint by 16.4% during the 1st quarter. Renaissance Technologies LLC now owns 2,580,153 shares of the company’s stock valued at $24,537,000 after acquiring an additional 363,200 shares during the last quarter. Finally, SG Americas Securities LLC grew its holdings in shares of AvePoint by 335.2% during the first quarter. SG Americas Securities LLC now owns 2,391,696 shares of the company’s stock worth $22,745,000 after purchasing an additional 1,842,124 shares in the last quarter. Hedge funds and other institutional investors own 44.49% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on AVPT shares. Wall Street Zen upgraded shares of AvePoint from a “hold” rating to a “buy” rating in a research report on Saturday, September 12th. Stephens upped their price target on shares of AvePoint from $16.00 to $17.00 and gave the company an “overweight” rating in a research note on Monday, September 21st. Citigroup reaffirmed a “neutral” rating on shares of AvePoint in a report on Wednesday, August 12th. Cantor Fitzgerald reiterated an “overweight” rating on shares of AvePoint in a research note on Tuesday, September 22nd. Finally, Evercore reissued an “outperform” rating and set a $16.00 target price on shares of AvePoint in a report on Friday, August 7th. Ten research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $16.36.

View Our Latest Report on AVPT

AvePoint Company Profile

(Get Free Report)

AvePoint, Inc (NASDAQ: AVPT) provides data-management, governance and protection solutions for organizations using cloud collaboration platforms. Its products are designed to help businesses migrate, manage, protect and optimize data across services such as Microsoft 365, SharePoint, Dynamics 365 and Salesforce.

The company’s offerings include cloud backup and recovery, data migration, records and information management, compliance, security and workspace governance. AvePoint delivers these capabilities through its cloud-based platform and related software, helping organizations manage data throughout its lifecycle while supporting collaboration and regulatory requirements.

Founded in 2001, AvePoint serves customers globally across a range of industries, including public-sector organizations, education, healthcare and commercial enterprises.

Recommended Stories

Insider Buying and Selling by Quarter for AvePoint (NASDAQ:AVPT)

Receive News & Ratings for AvePoint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AvePoint and related companies with MarketBeat.com's FREE daily email newsletter.